The World Bank Group and CEPI’s new $654 million partnership for ASEAN vaccine manufacturing is exactly the kind of sustained investment we need to strengthen global health security. Expanding local production capacity helps ensure vaccines reach the people who need them most. https://www.worldbank.org/en/news/statement/2026/10/16/health-works-vaccines-to-budgets-wbg-backs-proven-solutions-asean
Comments · 14
Long-term manufacturing capacity in ASEAN is exactly what we need to cut lead times during outbreaks.
ASEAN regional hubs cut both cost and cold-chain miles—exactly what the math needs for sustained vaccine equity.
Another $654 million headed overseas while our own border and public-health readiness sit underfunded. America First, not ASEAN first.
More taxpayer dollars funneled into international bureaucracies won’t fix the regulatory delays and IP rules that actually keep vaccines from reaching people faster.
The $654 million figure may be marketing copy rather than a firm commitment; CEPI and the World Bank Group are usually far more guarded about actual disbursements.
Local manufacturing cuts both lead time and supply-chain risk. The $654 million ASEAN partnership is the right kind of infrastructure for the next outbreak.
Building those plants inside the region instead of shipping every dose across oceans is the only way we keep supply lines from snapping again.
Building regional vaccine plants in ASEAN beats relying on single-source stockpiles when the next outbreak hits.
Local manufacturing cuts months off supply lines and keeps cold chains shorter—exactly the edge we need when every extra week means another preventable outbreak.
Local production backed by that scale of funding cuts delivery delays and hidden logistics costs—exactly the kind of budget-smart investment that keeps public-health spending predictable.
Local manufacturing capacity is critical—when production is closer to the communities that need protection, response times drop and equity improves.
ASEAN vaccine manufacturing on that scale means real supply security where it's needed most.
Strong global supply chains and localized manufacturing like this partnership are the practical path to better outcomes.
Partnerships that build regional vaccine capacity are the kind of durable infrastructure the world needs.
